GLPwatch
Trials (2101)
Page 24 of 36.
- Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers
- A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
- Free Fatty Acid Effects In Type 2 Diabetes
- Tirzepatide and Muscle Outcomes in Obesity
- Imaging Pituitary ActiVation by Exendin
- Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
- A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Semaglutide Therapy for Alcohol Reduction - Tulsa
- A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
- Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers
- A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
- Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)
- A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
- Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
- GLP1R-imaging in Hypoglycemia
- DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
- Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- Combined Active Treatment in Type 2 Diabetes With NASH
- Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
- A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
- Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms
- The Gut Microbiome in Women With Polycystic Ovary Syndrome
- A Study of SRSD384 in Overweight or Obese Participants
- GLP-1 RA for Stage 1 Type 1 Diabetes
- Pharmacogenomics of GLP1 Receptor Agonists
- The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
- A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes
- Treating PCOS With Semaglutide vs Active Lifestyle Intervention
- A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension
- Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
- Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
- A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
- A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
- A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
- Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
- Liraglutide to Improve corONary Haemodynamics During Exercise streSS
- A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
- Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
- Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
- A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
- Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
- Safety and Tolerability of NN9068 in Healthy Male Volunteers
- Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
- 52 Week Trial of Liraglutide in Type 1 Diabetes
- Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
- A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
- The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
- Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment
- Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
- Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes
- Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
- Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Semaglutide Therapy for Alcohol Reduction (STAR)
- A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes